Monsanto announced today that it is pursuing a divestiture of its dairy product, POSILAC® bovine somatotropin (commonly known as rBST). Additional details have not been disclosed at this time. “While POSILAC is a strong product for the business, we believe repositioning the business with a strategic owner will allow Monsanto to focus on the growth of its core seeds and … Read More